A drug with the SMILES CN1CCN(C(=O)C2=C[C@H](c3ccc4c(c3)OCO4)C[C@H](OCCCCO)O2)CC1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of -8.059%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CN1CCN(C(=O)C2=C[C@H](c3ccc4c(c3)OCO4)C[C@H](OCCCCO)O2)CC1
CN1CCN(C(=O)C2=C[C@H](c3ccc4c(c3)OCO4)C[C@H](OCCCCO)O2)CC1
[(2R,4R)-4-(1,3-benzodioxol-5-yl)-2-(4-hydroxybutoxy)-3,4-dihydro-2H-pyran-6-yl]-(4-methylpiperazin-1-yl)methanone